AAAAAA
Results:
1-14
|
Results: 14
Authors:
Karahan, SC
Deger, O
Orem, A
Ucar, F
Erem, C
Alver, A
Onder, E
Citation: Sc. Karahan et al., The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus, CLIN CH L M, 39(2), 2001, pp. 109-115
Authors:
Abes, M
Sarihan, H
Deger, O
Uydu, HA
Citation: M. Abes et al., The effect of ATP-MgCl2 on prevention of reperfusion injury after unilateral testicular torsion, EUR J PED S, 11(4), 2001, pp. 255-258
Authors:
Erem, C
Yildiz, R
Kavgaci, H
Karahan, C
Deger, O
Can, G
Telatar, M
Citation: C. Erem et al., Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city), DIABET RE C, 54(3), 2001, pp. 203-208
Authors:
Bilici, M
Efe, H
Koroglu, MA
Uydu, HA
Bekaroglu, M
Deger, O
Citation: M. Bilici et al., Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments, J AFFECT D, 64(1), 2001, pp. 43-51
Authors:
Erem, C
Uslu, T
Deger, O
Tosun, M
Kavgaci, H
Citation: C. Erem et al., Increased plasma lipoprotein (a) concentrations in Behcet's disease and its relation to vascular events, HEART, 84(2), 2000, pp. 208-209
Authors:
Bekaroglu, M
Deger, O
Karahan, SC
Bilici, M
Soylu, C
Orem, A
Citation: M. Bekaroglu et al., Effects of antidepressant treatments on polymorphonuclear elastase levels in patients with depression, J AFFECT D, 59(3), 2000, pp. 175-182
Authors:
Orem, A
Cimsit, G
Deger, O
Vanizor, B
Karahan, SC
Citation: A. Orem et al., Autoantibodies against oxidatively modified low-density lipoprotein in patients with Behcet's disease, DERMATOLOGY, 198(3), 1999, pp. 243-246
Authors:
Orem, A
Vanizor, B
Cimsit, G
Kiran, E
Deger, O
Malkoc, M
Citation: A. Orem et al., Decreased nitric oxide production in patients with Behcet's disease, DERMATOLOGY, 198(1), 1999, pp. 33-36
Authors:
Orem, A
Cimsit, G
Deger, O
Orem, C
Vanizor, B
Citation: A. Orem et al., The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis, CLIN CHIM A, 284(1), 1999, pp. 81-88
Authors:
Efe, H
Deger, O
Kirci, D
Karahan, SC
Orem, A
Calapoglu, M
Citation: H. Efe et al., Decreased neutrophil antioxidative enzyme activities and increased lipid peroxidation in hyperlipoproteinemic human subjects, CLIN CHIM A, 279(1-2), 1999, pp. 155-165
Authors:
Cimsit, G
Orem, A
Deger, O
Alpay, K
Kiran, E
Orem, C
Citation: G. Cimsit et al., The variation of serum lipoprotein (a) level with disease activity in psoriasis - Reply, BR J DERM, 140(3), 1999, pp. 566-567
Authors:
Erem, C
Deger, O
Bostan, M
Orem, A
Sonmez, M
Ulusoy, S
Telatar, M
Citation: C. Erem et al., Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications, ACT CARDIOL, 54(4), 1999, pp. 203-207
Authors:
Erem, C
Deger, O
Bostan, M
Orem, A
Sonmez, M
Ulusoy, S
Telatar, M
Citation: C. Erem et al., Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects, ACT CARDIOL, 54(2), 1999, pp. 77-81
Authors:
Kapicioglu, Z
Kalyoncu, IN
Deger, O
Can, G
Citation: Z. Kapicioglu et al., Effect of a somatostatin analogue (SMS 201-995) on tear secretion in rats, INT OPHTHAL, 22(1), 1998, pp. 43-45
Risultati:
1-14
|